In recent years, HALP has emerged as a new prognostic biomarker in various malignant and acute diseases related to all-cause and cardiovascular mortality (12, 13), while the association of the HLPA score with renal prognosis in kidney disease, such as IgAN, is limited. The gene discussed is NAT10; the disease is kidney disorder.